Review of Evidence Supporting the Arista™ Absorbable Powder Hemostat

References

• Stokes ME, Ye X, Shah M, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res. 2011;11(1):135. doi:10.1186/1472-6963-11-135
   PubMed Web of Science ®Google Scholar
• Bruckner BA, Blau LN, Rodriguez L, et al. Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures. J Cardiothor Surg. 2014;9(1):134. doi:10.1186/s13019-014-0134-4
   PubMedGoogle Scholar
• Schreiber MA, Neveleff DJ. Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings. AORN J. 2011;94(5):S1–20. doi:10.1016/j.aorn.2011.09.018
   PubMedGoogle Scholar
• Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: anemia and blood transfusion in the critically ill--current clinical practice in the United States. Crit Care Med. 2004;32(1):39–52. doi:10.1097/01.CCM.0000104112.34142.79
   PubMed Web of Science ®Google Scholar
• Boucher BA, Hannon TJ. Blood management: a primer for clinicians. Pharmacotherapy. 2007;27(10):1394–1411. doi:10.1592/phco.27.10.1394
   PubMed Web of Science ®Google Scholar
• Tackett SM, Sugarman R, Kreuwel HT, et al. Hospital economic impact from hemostatic matrix usage in cardiac surgery. J Med Econ. 2014;17(9):670–676. doi:10.3111/13696998.2014.928638
   PubMedGoogle Scholar
• Martyn D, Meckley LM, Miyasato G, et al. Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostats. Clinicoecon Outcomes Res. 2015;7:567–574. doi:10.2147/CEOR.S88698
   PubMed Web of Science ®Google Scholar
• AORN. Management of surgical hemostasis. An independent study guide; 2013.
   Google Scholar
• Docimo G, Filograna Pignatelli M, Ferrandes S, et al. Role of absorbable polysaccharide hemostatic powder in the prevention of bleeding and wound events after thyroid surgery. J Clin Med. 2023;12(17):5684. doi:10.3390/jcm12175684
   PubMed Web of Science ®Google Scholar
• Neveleff DJ. Optimizing hemostatic practices: matching the appropriate hemostat to the clinical situation. AORN J. 2012;96(5):S1–S17. doi:10.1016/j.aorn.2012.08.005
   PubMedGoogle Scholar
• Patrone R, Gambardella C, Romano RM, et al. The impact of the ultrasonic, bipolar and integrated energy devices in the adrenal gland surgery: literature review and our experience. BMC Surg. 2019;18(Suppl 1):123. doi:10.1186/s12893-018-0457-5
   PubMed Web of Science ®Google Scholar
• Gambardella C, Clarizia G, Patrone R, et al. Advanced hemostasis in axillary lymph node dissection for locally advanced breast cancer: new technology devices compared in the prevention of seroma formation. BMC Surg. 2019;18(Suppl 1):125. doi:10.1186/s12893-018-0454-8
   PubMedGoogle Scholar
• Vecchio R, Catalano R, Basile F, et al. Topical hemostasis in laparoscopic surgery. G Chir. 2016;37(6):266–270. doi:10.11138/gchir/2016.37.6.266
   PubMedGoogle Scholar
• Bruckner BA, Ngo U, Ramchandani M, et al. Application techniques of a novel hemostat in cardiac operations: HEMOBLAST. J Card Surg. 2019;34(9):849–853. doi:10.1111/jocs.14171
   PubMed Web of Science ®Google Scholar
• Tompeck AJ, Gajdhar AUR, Dowling M, et al. A comprehensive review of topical hemostatic agents: the good, the bad, and the novel. J Trauma Acute Care Surg. 2020;88(1):E1–E21. doi:10.1097/TA.0000000000002508
   PubMed Web of Science ®Google Scholar
• Chiara O, Cimbanassi S, Bellanova G, et al. A systematic review on the use of topical hemostats in trauma and emergency surgery. BMC Surg. 2018;18(1):68. doi:10.1186/s12893-018-0398-z
   PubMedGoogle Scholar
• Vyas KS, Saha SP. Comparison of hemostatic agents used in vascular surgery. Expert Opin Biol Ther. 2013;13(12):1663–1672. doi:10.1517/14712598.2013.848193
   PubMed Web of Science ®Google Scholar
• Offodile AC, Chen B, Aherrera AS, et al. Microporous polysaccharide hemospheres potentiate ischemia-induced skin flap necrosis in a murine model. Plast Reconstr Surg. 2017;139(1):59e–66e. doi:10.1097/PRS.0000000000002907
   PubMed Web of Science ®Google Scholar
• MacDonald MH, Wang AY, Clymer JW, et al. An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models. Med Devices. 2017;10:273–279. doi:10.2147/MDER.S140663
   Google Scholar
• Korell M, Ziegler N, De Wilde RL. Use of modified polysaccharide 4DryField PH for adhesion prevention and hemostasis in gynecological surgery: a two-center observational study by second-look laparoscopy. Biomed Res. Int. 2016;2016:1. doi:10.1155/2016/3029264
   Web of Science ®Google Scholar
• Spotnitz WD, Burks S. State-of-The-art review: hemostats, sealants, and adhesives II: update as well as how and when to use the components of the surgical toolbox. Clin Appl Thromb Hemost. 2010;16(5):497–514. doi:10.1177/1076029610363589
   PubMed Web of Science ®Google Scholar
• Ethicon. SURGICEL® Powder. Absorbable hemostatic powder (oxidized regenerated cellulose). 389894R06 - Surgicel^® Powder IFU (Code 3013SP)(Non-CE marked); 2018. Available from: https://hostedvl106.quosavl.com/qb/. Accessed March 26, 2024.
   Google Scholar
• Ibrahim MF, Aps C, Young CP. A foreign body reaction to Surgicel mimicking an abscess following cardiac surgery. Eur J Cardiothorac Surg. 2002;22(3):489–90; author reply 90. doi:10.1016/S1010-7940(02)00328-7
   PubMed Web of Science ®Google Scholar
• Eto K, Matsumoto M, Kubo Y, Kemmochi R. Superior vena cava syndrome caused by a swollen absorbable haemostat after repair of ischaemic mitral regurgitation. J Cardiothorac Surg. 2014;9(1):1. doi:10.1186/1749-8090-9-1
   PubMedGoogle Scholar
• Dogan S, Kocaeli H, Doygun M. Oxidised regenerated cellulose as a cause of paraplegia after thoracotomy: case report and review of the literature. Spinal Cord. 2005;43(7):445–447. doi:10.1038/sj.sc.3101632
   PubMed Web of Science ®Google Scholar
• Schonauer C, Tessitore E, Barbagallo G, et al. The use of local agents: bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J. 2004;13(Suppl 1):S89–96. doi:10.1007/s00586-004-0727-z
   PubMed Web of Science ®Google Scholar
• Rustagi T, Patel K, Kadrekar S, Jain A. Oxidized cellulose (Surgicel) causing postoperative cauda equine syndrome. Cureus. 2017;9:7.
   Google Scholar
• Badenes D, Pijuan L, Curull V, Sanchez-Font A. A foreign body reaction to Surgicel® in a lymph node diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Ann Thorac Med. 2017;12(1):55–56. doi:10.4103/1817-1737.197780
   PubMed Web of Science ®Google Scholar
• Patane F, Zingarelli E, Verzini A, Di Summa M. Complication due to excessive use of Surgicel. Eur J Cardiothorac Surg. 2001;20(5):1034. doi:10.1016/S1010-7940(01)00967-8
   PubMedGoogle Scholar
• Ethicon. SURGICEL® ORIGINAL, SURGICEL® NU-KNIT™ and SURGICEL® FIBRILLAR™ Non CE Marked IFU; 2018. Available from: https://hostedvl106.quosavl.com/qb/. Accessed March 26, 2024.
   Google Scholar
• Berkow AE. Surgery. Cornstarch peritonitis following the trail of the surgeon’s gloves. Postgrad Med. 1976;59(1):231–236. doi:10.1080/00325481.1976.11716541
   PubMed Web of Science ®Google Scholar
• Woods JA, Morgan RF, Watkins FH, Edlich RF. Surgical glove lubricants: from toxicity to opportunity. J Emerg Med. 1997;15(2):209–220. doi:10.1016/S0736-4679(96)00349-6
   PubMedGoogle Scholar
• Edlich RF, Long WB, Gubler DK, et al. Dangers of cornstarch powder on medical gloves: seeking a solution. Ann Plast Surg. 2009;63(1):111–115. doi:10.1097/SAP.0b013e3181ab43ae
   PubMed Web of Science ®Google Scholar
• Edlich RF, Long WB, Gubler KD, et al. Citizen’s Petition to Food and Drug Administration to ban cornstarch powder on medical gloves: maltese cross birefringence. Am J Emerg Med. 2009;27(2):227–235. doi:10.1016/j.ajem.2008.10.009
   PubMed Web of Science ®Google Scholar
• Nilsson G, Gold J Characterization of crystallinity in starch hemostatic products. Materials for Tomorrow – Chalmers Annual Materials Science Initiative Seminar. Gothenburg, Sweden; 2013.
   Google Scholar
• Suarez-Kelly LP, Pasley WH, Clayton EJ, et al. Effect of topical microporous polysaccharide hemospheres on the duration and amount of fluid drainage following mastectomy: a prospective randomized clinical trial. BMC Cancer. 2019;19(1). doi:10.1186/s12885-019-5293-1
   PubMedGoogle Scholar
• Humphreys MR, Lingeman JE, Terry C, et al. Renal injury and the application of polysaccharide hemospheres: a laparoscopic experimental model. J Endourol. 2008;22(6):1375–1381. doi:10.1089/end.2008.0008
   PubMed Web of Science ®Google Scholar
• Capella-Monsonís H, Shridhar A, Chirravuri B. A comparative study of the resorption and immune response for two starch-based hemostat powders. J Surg Res. 2023;282:210–224. doi:10.1016/j.jss.2022.09.022
   PubMed Web of Science ®Google Scholar
• Bard Davol Inc. AristaTM AH Instructions for Use. PK3798864; 2015.
   Google Scholar
• Ji X, Xing C, Shi X United States Patent. Patent No. US8,575,132 B2. Nov. 5, 2013; 2013.
   Google Scholar
• Singh RK, Baumgartner B, Mantei JR, et al. Hemostatic comparison of a polysaccharide powder and a gelatin powder. J Invest Surg. 2019;32(5):393–401. doi:10.1080/08941939.2017.1423421
   PubMed Web of Science ®Google Scholar
• Murat FJ, Le CQ, Ereth MH, et al. Evaluation of microporous polysaccharide hemospheres for parenchymal hemostasis during laparoscopic partial nephrectomy in the porcine model. JSLS. 2006;10(3):302–306.
   PubMedGoogle Scholar
• Humphreys MR, Castle EP, Andrews PE, et al. Microporous polysaccharide hemospheres for management of laparoscopic trocar injury to the spleen. Am J Surg. 2008;195(1):99–103. doi:10.1016/j.amjsurg.2007.03.006
   PubMed Web of Science ®Google Scholar
• Singh P, Vasques D, Deleon F. Microporous polysaccharide hemospheres for adhesion prevention: a randomized controlled trial. J Gynecol Surg. 2013;29(4):196–202. doi:10.1089/gyn.2013.0007
   Google Scholar
• Tschan CA, Niess M, Schwandt E, Oertel J. Safety and efficacy of microporous polysaccharide hemospheres in neurosurgery. Neurosurgery. 2011;69(SUPPL. 1):ons49–ons63. doi:10.1227/NEU.0b013e3182155a52
   PubMedGoogle Scholar
• Hermans MHE, Brown L, Darmoc M. Adhesion prevention in an intraperitoneal wound model: performance of two resorbable hemostats in a controlled study in rabbits. J Biomed Mater Res. 2012;100 B(6):1621–1626. doi:10.1002/jbm.b.32730
   Google Scholar
• Erdogan H, Kelten B, Tuncdemir M, et al. Hemostasis vs. epidural fibrosis?: a comparative study on an experimental rat model of laminectomy. Neurologia I Neurochirurgia Polska. 2016;50(5):323–330. doi:10.1016/j.pjnns.2016.05.002
   PubMed Web of Science ®Google Scholar
• Bruckner BA, Loebe M. Microporous polysaccharide hemosphere absorbable hemostat (AristaAH) use in re-operative cardiac surgical procedures. US Cardiol. 2012;9(2):96–98. doi:10.15420/usc.2012.9.2.96
   Google Scholar
• Bruckner BA, Loebe M. The use of an absorbable microporous polysaccharide hemosphere haemostat (AristaAH) in ventricular assist device implant and cardiac transplantation procedures. Eur Cardiol. 2012;8(2):125–127. doi:10.15420/ecr.2012.8.2.125
   Google Scholar
• Sindwani R. Use of novel hemostatic powder MPH for endoscopic sinus surgery: initial impressions. Otolaryngology. 2009;140(2):262–263. doi:10.1016/j.otohns.2008.11.009
   Google Scholar
• Phillips PP. Safety and efficacy of Arista powder in 514 nasal septal and sinus surgery patients. Otolaryngology. 2013;149(2):P135. doi:10.1177/0194599813495815a301
   Google Scholar
• Galarza M, Porcar OP, Gazzeri R, Martnez-Lage JF. Microporous Polysaccharide Hemospheres (MPH) for cerebral hemostasis: a preliminary report. World Neurosurg. 2011;75(3–4):491–494. doi:10.1016/j.wneu.2010.10.008
   PubMed Web of Science ®Google Scholar
• Reynbakh O, Akhrass P, Souvaliotis N, et al. Use of MPH hemostatic powder for electrophysiology device implantation reduces postoperative rates of pocket hematoma and infection. Curr Med Res Opin. 2018;34(10):1861–1867. doi:10.1080/03007995.2018.1476847
   PubMed Web of Science ®Google Scholar
• Antisdel JL, West-Denning JL, Sindwani R. Effect of microporous polysaccharide hemospheres (MPH) on bleeding after endoscopic sinus surgery: randomized controlled study. Otolaryngology. 2009;141(3):353–357. doi:10.1016/j.otohns.2009.06.078
   Google Scholar
• Antisdel JL, Matijasec JL, Ting JY, Sindwani R. Microporous polysaccharide hemospheres do not increase synechiae after sinus surgery: randomized controlled study. Am J Rhinol Aller. 2011;25(4):268–271. doi:10.2500/ajra.2011.25.3619
   PubMed Web of Science ®Google Scholar
• Nunez-Nateras R, Hurd KJ, Ferrigni EN, et al. Athermal nerve sparing robot-assisted radical prostatectomy: initial experience with microporous polysaccharide hemospheres as a topical hemostatic agent. World j Urol. 2013;31(3):523–527. doi:10.1007/s00345-011-0815-8
   PubMed Web of Science ®Google Scholar
• Gilbert DR, Angell J, Abaza R. Evaluation of absorbable hemostatic powder for prevention of lymphoceles following robotic prostatectomy with lymphadenectomy. Urology. 2016;98:75–80. doi:10.1016/j.urology.2016.06.071
   PubMed Web of Science ®Google Scholar
• Gleason S, Mehl D, Payne W, et al. Microporous polysaccharide hemosphere efficacy and safety in primary total knee arthroplasty. J Orthopa. 2019;16(1):19–24. doi:10.1016/j.jor.2018.11.006
   PubMed Web of Science ®Google Scholar
• Palacios DA, McDonald M, Miyake M, Rosser CJ. Pilot study comparing the two hemostatic agents in patients undergoing partial nephrectomy. BMC Res Notes. 2013;6(1):399. doi:10.1186/1756-0500-6-399
   PubMedGoogle Scholar
• Antisdel JL, Meyer A, Comer B, et al. Product comparison model in otolaryngology: equivalency analysis of absorbable hemostatic agents after endoscopic sinus surgery. Laryngoscope. 2016;126(Supplement 2):S5–S13. doi:10.1002/lary.25678
   PubMedGoogle Scholar
• Kunduz E, Aysan E, Idiz UO, et al. Evaluation of local hemostatic effect of microporous polysaccharide hemospheres products in thyroid surgery: a prospective randomized controlled study. Turk J Surg. 2019;35(1):49–53. doi:10.5578/turkjsurg.4162
   PubMed Web of Science ®Google Scholar
• Tan SR, Tope WD. Effectiveness of microporous polysaccharide hemospheres for achieving hemostasis in Mohs micrographic surgery. Dermatologic Surg. 2004;30(6):908–914. doi:10.1111/j.1524-4725.2004.30261.x
   PubMed Web of Science ®Google Scholar
• Benlier E, Top H, Aygit AC, et al. Microvascular anastomosis with minimal suture and arista: an experimental study. J Reconstruct Microsurg. 2007;23(6):311–315. doi:10.1055/s-2007-985213
   PubMed Web of Science ®Google Scholar
• Egeli T, Sevinc AI, Bora S, et al. Microporous polysaccharide hemospheres and seroma formation after mastectomy and axillary dissection in rats. Balkan Med J. 2012;29(2):179–183. doi:10.5152/balkanmedj.2012.005
   PubMed Web of Science ®Google Scholar
• Ereth MH, Schaff M, Ericson EF, et al. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model. Neurosurgery. 2008;63(4 SUPPL):ONS369–ONS72.
   Web of Science ®Google Scholar
• Hoffmann NE, Siddiqui SA, Agarwal S, et al. Choice of hemostatic agent influences adhesion formation in a rat cecal adhesion model. J Surg Res. 2009;155(1):77–81. doi:10.1016/j.jss.2008.08.008
   PubMed Web of Science ®Google Scholar
• Emmez H, Tonge M, Tokgoz N, et al. Radiological and histopathological comparison of microporous polysaccharide hemospheres and oxidized regenerated cellulose in the rabbit brain: a study of efficacy and safety. Turk Neurosurg. 2010;20(4):485–491. Turkish. doi:10.5137/1019-5149.JTN.3300-10.2
   PubMed Web of Science ®Google Scholar
• Ereth MH, Dong Y, Schrader LM, et al. Microporous polysaccharide hemospheres do not enhance abdominal infection in a rat model compared with gelatin matrix. Surg Infect. 2009;10(3):273–276. doi:10.1089/sur.2007.033
   PubMed Web of Science ®Google Scholar
• Antisdel JL, Janney CG, Long JP, Sindwani R. Hemostatic agent Microporous Polysaccharide Hemospheres (MPH) does not affect healing or intact sinus mucosa. Laryngoscope. 2008;118(7):1265–1269. doi:10.1097/MLG.0b013e31816c7bc9
   PubMed Web of Science ®Google Scholar
• Ereth M, Sibonga J, Oliver W, et al. Microporous polysaccharide hemospheres do not inhibit bone healing compared to bone wax or microfibrillar collage. Orthopedics. 2008;31(3):1–4.
   Google Scholar
• Barkun AN, Adam V, Lu Y, et al. Using hemospray improves the cost-effectiveness ratio in the management of upper gastrointestinal nonvariceal bleeding. J Clin Gastroenterol. 2018;52(1):36–44. doi:10.1097/MCG.0000000000000709
   PubMed Web of Science ®Google Scholar
• Joshi MR, Latham J, Okorogheye G. Use of a flowable haemostat versus an oxidised regenerated cellulose agent in primary elective cardiac surgery: economic impact from a UK healthcare perspective. J Cardiothorac Surg. 2017;12(1):107. doi:10.1186/s13019-017-0660-y
   PubMedGoogle Scholar
• Makhija D, Rock M, Xiong Y, et al. Cost-consequence analysis of different active flowable hemostatic matrices in cardiac surgical procedures. J Med Econ. 2017;20(6):565–573. doi:10.1080/13696998.2017.1284079
   PubMed Web of Science ®Google Scholar
• Wood E. Advance preparation tends to waste many absorbable hemostatic agents. OR Manag. 2016;3:32.
   Google Scholar
• ACOG. Topical hemostatic agents at time of obstetric and gynecologic surgery. ACOG Committee Opinion. Obsetr Gynecol. 2020;136(4):e81–e9. doi:10.1097/AOG.0000000000004104
   PubMed Web of Science ®Google Scholar
• Ramirez MG, Niu X, Epstein J, Yang D. Cost-consequence analysis of a hemostatic matrix alone or in combination for spine surgery patients. J Med Econ. 2018;21(10):1041–1046. doi:10.1080/13696998.2018.1513261
   PubMed Web of Science ®Google Scholar